[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369809-105":59,"doc-detail-369809-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","the-anti-glioblastoma-effects-of-novel-liposomal-formulations-loaded-with-cannabidiol-celecoxib-and-25-dimethylcelecoxib","The Anti-Glioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and 2,5-Dimethylcelecoxib","","Glioblastoma therapy remains limited by the blood-brain barrier and by dysregulated tumor signaling that drives drug resistance. This study develops liposomal nanoformulations encapsulating cannabidiol (CBD), celecoxib (CELE), and 2,5-dimethylcelecoxib (DMC), including their combinations, to evaluate anti-GBM properties. Five formulations were prepared by modified thin-film hydration and assessed in GBM cell lines and astrocytes using MTT cytotoxicity and flow cytometry. Nrf2, Wnt/β-catenin, and NF-κB signaling were measured by qPCR, Western blot, and ELISA. Results show significant anti-GBM activity via apoptosis, oxidative stress induction, and pathway modulation; CBD+CELE suppressed Wnt/β-catenin and NF-κB while activating Nrf2, supporting translational potential while requiring further in vivo validation.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-anti-glioblastoma-effects-of-novel-liposomal-formulations-loaded-with-cannabidiol-celecoxib-and-25-dimethylcelecoxib/369809/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-anti-glioblastoma-effects-of-novel-liposomal-formulations-loaded-with-cannabidiol-celecoxib-and-25-dimethylcelecoxib/369809.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in glioblastoma treatment?","Question",{"text":112,"@type":113},"Glioblastoma therapy efficacy is limited by poor blood-brain barrier penetration and dysregulated tumor signaling that promotes drug resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the liposomal nanoformulations prepared and tested?",{"text":117,"@type":113},"Five formulations were made using a modified thin-film hydration technique and evaluated in GBM cell lines and non-cancerous astrocytes using MTT and flow-cytometry-based apoptosis, cell cycle, and oxidative stress analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What signaling pathways did the formulations affect?",{"text":121,"@type":113},"The study assessed Nrf2, Wnt/β-catenin, and NF-κB pathways using qPCR, Western blot, and ELISA, finding CBD+CELE suppression of Wnt/β-catenin and NF-κB with activation of Nrf2.",{"name":123,"@type":110,"acceptedAnswer":124},"Was synergy observed between CBD and CELE or DMC?",{"text":125,"@type":113},"No clear synergistic or additive effects were observed between CBD and CELE or DMC when co-loaded, while the CBD+CELE combination showed meaningful pathway suppression and Nrf2 activation.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},369809,1790320214,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nThe Anti-Glioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and 2,5-Dimethylcelecoxib  \nAnna Rybarczyk 1,2, Aleksandra Majchrzak-Celi ´nska 1,†, Ludwika Piwowarczyk 3 and  \nVioletta Krajka-Ku´zniak 1, *,†  \nAcademic Editor: Giuseppe De Rosa  \nReceived: 14 July 2025  \nRevised: 2 August 2025  \nAccepted: 4 August 2025  \nPublished: 8 August 2025  \nCitation: Rybarczyk, A.; MajchrzakCeli ´nska, A.; Piwowarczyk, L.; Krajka-Ku´zniak, V. The AntiGlioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and  \n2,5-Dimethylcelecoxib. Pharmaceutics 2025, 17, 1031. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/pharmaceutics17081031](10.3390/pharmaceutics17081031)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Chair and Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Pozna ´n, Poland; [anna.rybarczyk@student.ump.edu.pl](anna.rybarczyk@student.ump.edu.pl) (A.R.);  \n[majchrzakcelinska@ump.edu.pl](majchrzakcelinska@ump.edu.pl) (A.M.-C.)  \n2 Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Pozna ´n, Poland  \n3 Chair and Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Pozna ´n, Poland; [lpiwowarczyk@ump.edu.pl](lpiwowarczyk@ump.edu.pl)  \n* [Correspondence: vkrajka@ump.edu.pl](Correspondence: vkrajka@ump.edu.pl); Tel.: +48-61-641-8470 † These authors contributed equally to this work.  \nAbstract  \nBackground/Objectives: Glioblastoma multiforme (GBM) therapy efficacy remains limited due to the poor blood-brain barrier-penetrating power of drugs as well as dysregulated cellular signaling pathways of tumor cells leading to drug resistance. Novel drug delivery systems such as liposome-based nanoformulations improve the bioavailability and stability of water-insoluble drugs, while co-delivery of two anti-cancer compounds can further increase their anti-tumor effectiveness due to synergistic effects. Thus, the aim of this study was to obtain liposomal nanoformulations encapsulating cannabidiol (CBD), celecoxib (CELE), and 2,5-dimethylcelecoxib (DMC) and their combinations and to verify their anti-GBM properties. Methods: Five liposomal nanoformulations were obtained using a modified thin-film hydration technique. Two GBM cell lines and non-cancerous astrocytes were used for the biological evaluation of the tested nanoformulations. The cytotoxicity experiments were performed using the MTT assay, whereas flow cytometry-based analysis assessed the effect of the liposomes on apoptosis, cell cycle distribution, and oxidative stress. To determine the impact of the tested nanoformulations on Nrf2, Wnt/β-catenin, and NF-κB signaling pathways, qPCR, Western blot and ELISA techniques were used. Results: The findings of this study demonstrate that liposomal nanoformulations containing CBD, CELE, and DMC exhibit significant anti-GBM activity, particularly through the induction of apoptosis and oxidative stress and modulation of the key signaling pathways. Although no clear synergistic/additive effects were observed between CBD and CELE or DMC when co-loaded in nanoformulations, the combination of CBD and CELE effectively suppressed Wnt/β-catenin and NF-κB signaling and activated the Nrf2 pathway. These results support the therapeutic potential of liposome-based co-delivery of CBD and CELE in GBM therapy. However, further in vivo studies are warranted to determine these nanoformulations’translational relevance and clinical applicability.  \nKeywords: Glioblastoma (GBM); cannabidiol (CBD); celecoxib (CELE); 2,5-dimethylcelecoxib (DMC)","cbCaidMkMuHAyLDL","https://ap.wps.com/l/cbCaidMkMuHAyLDL","pdf",6248455,23,"English","# Introduction\n# Materials and Methods\n## Nanoformulation preparation\n## Cell evaluation and assays\n## Signaling pathway analysis\n# Results and Discussion\n## Anti-GBM activity and mechanisms\n## Synergy/additivity of co-loaded drugs\n## Pathway modulation (Nrf2, Wnt/β-catenin, NF-κB)\n# Conclusions and Future Work","[{\"question\":\"What problem does the study address in glioblastoma treatment?\",\"answer\":\"Glioblastoma therapy efficacy is limited by poor blood-brain barrier penetration and dysregulated tumor signaling that promotes drug resistance.\"},{\"question\":\"How were the liposomal nanoformulations prepared and tested?\",\"answer\":\"Five formulations were made using a modified thin-film hydration technique and evaluated in GBM cell lines and non-cancerous astrocytes using MTT and flow-cytometry-based apoptosis, cell cycle, and oxidative stress analyses.\"},{\"question\":\"What signaling pathways did the formulations affect?\",\"answer\":\"The study assessed Nrf2, Wnt/β-catenin, and NF-κB pathways using qPCR, Western blot, and ELISA, finding CBD+CELE suppression of Wnt/β-catenin and NF-κB with activation of Nrf2.\"},{\"question\":\"Was synergy observed between CBD and CELE or DMC?\",\"answer\":\"No clear synergistic or additive effects were observed between CBD and CELE or DMC when co-loaded, while the CBD+CELE combination showed meaningful pathway suppression and Nrf2 activation.\"}]","The Anti-Glioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and 2,5-Dimethylcelecoxib | PDF",1790184655,58,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9dfacdc96dd0dfdb8401b24ab5542cb.webp",983,1390,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcc135ed863c37dd774404296755b3c3.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70f89f6c3271e50c8f6623f7f74289f6.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7d990a9eb92a7a87163700076c0a409.webp",980,1385]